Yantai-based biotech innovator RemeGen signed an exclusive worldwide licensing agreement with Seagen Inc on Aug 8.
The actual use of foreign capital in Yantai reached $1.26 billion, up 51.4 percent in the first half of this year.
The signing of the Regional Comprehensive Economic Partnership agreement is a wonderful thing.
Yantai has become a preferred place for multinational firms.
Yantai will host a promotional conference during the second Qingdao Multinationals Summit.
Yantai hosted an online dialogue with the top executives of the world's top 500 enterprises on June 28.